Trial Profile
The Role of DLBS1033 in The Management of Acute Non-ST Elevation of Myocardial Infarction (NSTEMI) Without Early Coronary Revascularization
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II/III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Lumbricus rubellus (Primary) ; Aspirin; Clopidogrel
- Indications Myocardial infarction
- Focus Therapeutic Use
- Sponsors Dexa Medica
- 18 Apr 2016 Planned End Date changed from 1 Feb 2018 to 1 Mar 2018.
- 18 Apr 2016 Status changed from recruiting to withdrawn prior to enrolment as the investigational cases were no longer relevant considering the recent implementation of our current national healthcare system.
- 25 Nov 2015 Planned End Date changed from 1 Aug 2017 to 1 Feb 2018 as reported by ClinicalTrials.gov record.